Skip to content

Clinical trials

Multiple Sclerosis, Relapsing-Remitting trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis, Relapsing-Remitting Clear all

612 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20026
200320
200411
200515
200622
200717
200817
200927
201029
201129
201223
201333
201427
201537
201618
201733
201822
201926
202027
202130
202227
202333
202429
202520
202624

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed366
Terminated66
Unknown status57
Recruiting49
Active, not recruiting29
Withdrawn23
Not yet recruiting15
Enrolling by invitation4
Suspended3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen78
Novartis Pharmaceuticals30
Merck KGaA, Darmstadt, Germany26
Bayer17
Teva Branded Pharmaceutical Products R&D, Inc.12
Hoffmann-La Roche11
GlaxoSmithKline9
Johns Hopkins University9
EMD Serono8
Genzyme, a Sanofi Company8

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis, Relapsing-Remitting612
Multiple Sclerosis301
Multiple Sclerosis, Chronic Progressive70
Fatigue28
Demyelinating Diseases16
Nervous System Diseases12
Recurrence12
Autoimmune Diseases11
Cognitive Dysfunction9
Autoimmune Diseases of the Nervous System6

Trials

Showing 1 to 25 of 612. Each trial links to its page on Pharma Observatory.

512 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.